A team from the academic and clinical arms of Northwestern Medicine has been assembled to study patient DNA and create customized therapies for Parkinson’s, Epilepsy, and ALS in a model called Personalized Neurology.
Northwestern Medicine scientists showed how enzyme inhibitors might be used to halt a molecular process that can cause neurodegeneration in patients with HIV.
A Northwestern Medicine study has found that black and white populations have similar risk for developing diabetes when all biological factors are considered, upending a long-held consensus.
From heart tissue repair to retinal cell development, scientific images helped bring to life the discoveries published by Feinberg faculty, trainees and students in 2017. See a selection of some of the most striking images of the year.
Scientists are one step closer to a stem cell treatment for muscular dystrophy after Northwestern Medicine investigators demonstrated improvements in muscle tissue differentiation in stem cells.
A device attached to a patient’s scalp that delivers a continuous dose of low-intensity electric fields improves survival and slows the growth of a deadly brain tumor, according to a new trial.
A newly-designed mutant herpes virus provides a strategy for the development of novel herpes virus vaccines.
A new study provides insights into a mechanism underlying Parkinson’s disease and suggests that an existing drug could be employed as a novel treatment.
Entrepreneurship has been rapidly expanding at Feinberg. Through a range of initiatives, medical school leadership anticipates that the culture of innovation will only continue to grow in coming years.
Feinberg reaffirmed its commitment to informatics and precision medicine by appointing Firas Wehbe, MD, PhD, as its first chief research informatics officer.